RxDoctor Payments Data

Rhonda Davis, DPM

Foot Surgery · Winchester, VANPI 1366490989

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 64.6% of it on its own, with 12 other manufacturers making up the rest.

$2,519in general payments, 2019–2025

Across 74 payments — averaging $34.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Melinta Therapeutics, LLC$138
  • Medtronic$124
  • Abbott$108
  • Integra Lifesciences Corporation$106
  • Acumed LLC$101
  • plus $315 from 7 others

What the payments were for

  • Food & beverage$2,46398%
  • Education$562%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew56$1,627
Melinta Therapeutics, LLC2$138
Medtronic2$124
Abbott1$108
Integra Lifesciences Corporation2$106
Acumed LLC1$101
Osiris Therapeutics Inc.1$100
Rikco International, LLC2$66
Convatec Inc.2$59
Paratek Pharmaceuticals, Inc.2$34
Organogenesis Inc.1$32
Mckesson Patient Care Solutions Inc.1$14
Kerecis Limited1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,519 in reported general payments places this provider in the 65th percentile of 34 foot surgery providers in Virginia.

See all foot surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$332,664
Medicare patients
548
Services billed
3,451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin51$931
Methylprednisolone100$713
Gabapentin110$628
Pregabalin33$355
Triamcinolone Acetonide15$321
Acetaminophen-CodeineAcetaminophen With Codeine19$179
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$178
Levofloxacin32$100
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$78
Tramadol Hcl20$65
Meloxicam21$58
Terbinafine Hcl13$36

Paid to pharmacies, not to this prescriber.

Other foot surgery in Winchester

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →